SLV Stock Overview
Operates as a contract research organization worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Selvita S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł50.90 |
| 52 Week High | zł73.00 |
| 52 Week Low | zł45.80 |
| Beta | 0.026 |
| 1 Month Change | -4.86% |
| 3 Month Change | -20.96% |
| 1 Year Change | -14.88% |
| 3 Year Change | -37.16% |
| 5 Year Change | 121.30% |
| Change since IPO | 142.38% |
Recent News & Updates
Recent updates
Is Selvita (WSE:SLV) Using Too Much Debt?
Sep 26
It's Unlikely That The CEO Of Selvita S.A. (WSE:SLV) Will See A Huge Pay Rise This Year
Jun 14Earnings Report: Selvita S.A. Missed Revenue Estimates By 7.1%
May 26Selvita's (WSE:SLV) Solid Earnings May Rest On Weak Foundations
Apr 03Selvita S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Apr 01Selvita S.A. (WSE:SLV) Analysts Just Cut Their EPS Forecasts Substantially
Oct 07We Think Selvita (WSE:SLV) Can Stay On Top Of Its Debt
Sep 28Here's Why Selvita (WSE:SLV) Has Caught The Eye Of Investors
Jun 02Selvita (WSE:SLV) Seems To Use Debt Quite Sensibly
Jun 09These 4 Measures Indicate That Selvita (WSE:SLV) Is Using Debt Reasonably Well
Feb 23If You Like EPS Growth Then Check Out Selvita (WSE:SLV) Before It's Too Late
Mar 31Here's What Selvita S.A.'s (WSE:SLV) Shareholder Ownership Structure Looks Like
Feb 25Here's Why We Don't Think Selvita's (WSE:SLV) Statutory Earnings Reflect Its Underlying Earnings Potential
Jan 22
Is Now The Time To Put Selvita (WSE:SLV) On Your Watchlist?
Dec 25Did You Miss Selvita's (WSE:SLV) Impressive 113% Share Price Gain?
Dec 02Shareholder Returns
| SLV | PL Life Sciences | PL Market | |
|---|---|---|---|
| 7D | -4.3% | -14.5% | -2.5% |
| 1Y | -14.9% | -26.1% | -4.5% |
Return vs Industry: SLV exceeded the Polish Life Sciences industry which returned -27.8% over the past year.
Return vs Market: SLV underperformed the Polish Market which returned -5.2% over the past year.
Price Volatility
| SLV volatility | |
|---|---|
| SLV Average Weekly Movement | 6.8% |
| Life Sciences Industry Average Movement | 7.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in PL Market | 8.6% |
| 10% least volatile stocks in PL Market | 3.3% |
Stable Share Price: SLV's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: SLV's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 387 | Boguslaw Sieczkowski | selvita.com |
Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, analytical and solid state chemistry, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, autoimmune/immunology, neurology, respiratory, and other.
Selvita S.A. Fundamentals Summary
| SLV fundamental statistics | |
|---|---|
| Market cap | zł934.29m |
| Earnings (TTM) | zł54.09m |
| Revenue (TTM) | zł334.42m |
17.3x
P/E Ratio2.8x
P/S RatioIs SLV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SLV income statement (TTM) | |
|---|---|
| Revenue | zł334.42m |
| Cost of Revenue | zł71.47m |
| Gross Profit | zł262.96m |
| Other Expenses | zł208.86m |
| Earnings | zł54.09m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.95 |
| Gross Margin | 78.63% |
| Net Profit Margin | 16.18% |
| Debt/Equity Ratio | 37.9% |
How did SLV perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 07:47 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Selvita S.A. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kamil Kliszcz | Biuro maklerskie mBanku |
| Beata Szparaga-Wasniewska | Biuro maklerskie mBanku |
| Sylwia Jaskiewicz | Dom Maklerski Banku Ochrony Srodowiska S.A. |